Multidimensional Characterization of Dyspnea in Children
Launched by ASSISTANCE PUBLIQUE - HÔPITAUX DE PARIS · Aug 11, 2022
Trial Information
Current as of July 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how to better understand and describe breathing difficulties, known as dyspnea, in children aged 6 to 17 years. Currently, there isn’t a specific tool that captures all the different ways children experience this symptom. The researchers believe that using a detailed evaluation scale, similar to ones used in adults, can help doctors assess and manage breathing issues more effectively in children. This includes conditions like asthma attacks and chronic illnesses such as cystic fibrosis.
To participate in this study, children must be experiencing breathing complaints and be receiving care at Trousseau Hospital's pediatric pulmonology department. Parents or guardians must also agree for their child to join the study. Children who have cognitive disorders that make it hard for them to understand the assessments, or who refuse to participate, will not be included. By taking part, participants can help improve how doctors understand and treat respiratory issues in children, potentially leading to better outcomes in the future.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Children aged between 6-17 years old at inclusion
- • Experiencing respiratory complaints at inclusion
- • Social security number
- • Children whom parents or legal representatives are present or reachable via phone call at inclusion
- • Non-opposition of parents or legal representatives to participate in the study
- • Children who are followed at or hospitalized in Trousseau hospital's pediatric pulmonology department for: asthma attack, acute respiratory insufficiency, acute exacerbation of a chronic respiratory disease, chronic respiratory insufficiency.
- • For the study of acute dyspnea: patients hospitalized for acute respiratory disease since less than 72h.
- • For the study of chronic dyspnea: children presenting with chronic respiratory disease.
- Exclusion Criteria:
- • Cognitive disorders making it impossible to understand self-assessment scales
- • Refusal of the child to participate in the research
- For the assessment of chronic dyspnea:
- • Children followed for a chronic respiratory pathology having presented an episode of acute respiratory decompensation in the 6 weeks preceding inclusion.
About Assistance Publique Hôpitaux De Paris
Assistance Publique - Hôpitaux de Paris (AP-HP) is a leading public hospital system in France, renowned for its commitment to healthcare excellence and innovative medical research. As a prominent clinical trial sponsor, AP-HP plays a pivotal role in advancing medical knowledge and improving patient care through rigorous scientific investigations across a wide range of therapeutic areas. With a focus on collaboration and interdisciplinary approaches, AP-HP leverages its extensive network of hospitals and expert clinicians to facilitate high-quality clinical trials that adhere to the highest ethical and regulatory standards, ultimately aiming to translate research findings into tangible health benefits for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials